Dr. Susan Boolbol, chief of breast surgery at Beth Israel Medical Center in New York City is scheduled to unveil a new breast cancer device at tomorrow's (Septemebr 13, 2012) American Society of Clinical Oncology's Breast Cance Symposium in San Francisco. Known as MarginProbe, this device is intended to help "surgeons determine in the operating room if they have removed all cancerous breast cancer tissue." By emitting an electric field and thus receiving a return signal from examined tissue, MarginProbe may help reduce repeat surgeries after lumpectimy "without compromising cosmetic effects."
To read more about MarginProbe, click here.
No comments:
Post a Comment